Compare ACA & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACA | LNTH |
|---|---|---|
| Founded | 2018 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.6B |
| IPO Year | 2018 | 2014 |
| Metric | ACA | LNTH |
|---|---|---|
| Price | $119.99 | $96.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $120.00 | $87.00 |
| AVG Volume (30 Days) | 247.7K | ★ 869.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 121.99 | N/A |
| EPS | 0.77 | ★ 1.80 |
| Revenue | ★ $2,883,400,000.00 | $343,374,000.00 |
| Revenue This Year | $5.26 | N/A |
| Revenue Next Year | $6.49 | $14.19 |
| P/E Ratio | $152.71 | ★ $51.90 |
| Revenue Growth | ★ 12.20 | 3.62 |
| 52 Week Low | $81.91 | $47.27 |
| 52 Week High | $135.58 | $98.27 |
| Indicator | ACA | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 69.50 |
| Support Level | $92.54 | $49.21 |
| Resistance Level | $132.24 | $98.27 |
| Average True Range (ATR) | 4.97 | 3.22 |
| MACD | -1.46 | 0.21 |
| Stochastic Oscillator | 20.97 | 86.67 |
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.